Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Eton Pharmaceuticals, Inc. before investing.

In this article, we go over a few key elements for understanding Eton Pharmaceuticals, Inc.’s stock price such as:

• Eton Pharmaceuticals, Inc.’s current stock price and volume
• Why Eton Pharmaceuticals, Inc.’s stock price changed recently
• Upgrades and downgrades for ETON from analysts
• ETON’s stock price momentum as measured by its relative strength

About Eton Pharmaceuticals, Inc. (ETON)

Before we jump into Eton Pharmaceuticals, Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing various product candidates, which are in late-stage development, including ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700 for Wilson disease; ET-800 for adrenal insufficiency; and ZENEO hydrocortisone autoinjector for adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.

Want to learn more about Eton Pharmaceuticals, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Eton Pharmaceuticals, Inc..

Eton Pharmaceuticals, Inc.’s Stock Price as of Market Close

As of August 14, 2026, 4:00 PM, CST, Eton Pharmaceuticals, Inc.’s stock price was $58.860.

Eton Pharmaceuticals, Inc. is up 44.26% from its previous closing price of $40.800.

During the last market session, Eton Pharmaceuticals, Inc.’s stock traded between $53.010 and $59.790. Currently, there are approximately 27.64 million shares outstanding for Eton Pharmaceuticals, Inc..

Eton Pharmaceuticals, Inc.’s price-earnings (P/E) ratio is currently at 93.4, which is high compared to the Pharmaceuticals industry median of 17.3. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Eton Pharmaceuticals, Inc. Stock Price History

Eton Pharmaceuticals, Inc.’s (ETON) price is currently up 26.8% so far this month.

During the month of August, Eton Pharmaceuticals, Inc.’s stock price has reached a high of $59.790 and a low of $40.610.

Over the last year, Eton Pharmaceuticals, Inc. has hit prices as high as $50.180 and as low as $14.270. Year to date, Eton Pharmaceuticals, Inc.’s stock is up 248.08%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Eton Pharmaceuticals, Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of August 13, 2026, there was 1 analyst who downgraded Eton Pharmaceuticals, Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Eton Pharmaceuticals, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Eton Pharmaceuticals, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Eton Pharmaceuticals, Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Eton Pharmaceuticals, Inc. (ETON) by visiting AAII Stock Evaluator.

Relative Price Strength of Eton Pharmaceuticals, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of August 13, 2026, Eton Pharmaceuticals, Inc. has a weighted four-quarter relative price strength of 23.44%, which translates to a Momentum Score of 93 and is considered to be Very Strong.

Want to learn more about how Eton Pharmaceuticals, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Eton Pharmaceuticals, Inc. Stock Price: Bottom Line

As of August 14, 2026, Eton Pharmaceuticals, Inc.’s stock price is $58.860, which is up 44.26% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Eton Pharmaceuticals, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.